Skip to content

The Difference Seen in Granulosa Cells and Immature Oocytes in IVF Treated Patients Sorted by Body Mass Index (BMI)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03020173
Enrollment
100
Registered
2017-01-13
Start date
2017-01-31
Completion date
2018-07-31
Last updated
2017-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Brief summary

This study aims to discover the connection between BMI and oocyte and granulosa consistencies.

Interventions

Laboratory analysis to determine composition of granulosa and oocytes

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Infertile women undergoing IVF * Consent to participate in study

Exclusion criteria

* Fertility preservation due to cancer * Endocrine disorders

Design outcomes

Primary

MeasureTime frameDescription
Measurement of composition of granulosa cells and oocytesOne yearLaboratory measurement of lipid and cholesterol amounts, mitochondrial distribution and telomere length according to BMI levels

Contacts

Primary ContactRinat Lift, MSc
rinatl@hy.health.gov.il
Backup ContactShira Raviv, MD
drshiraraviv@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026